<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35484639</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1550-9397</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine</Title><ISOAbbreviation>J Clin Sleep Med</ISOAbbreviation></Journal><ArticleTitle>Restless legs syndrome is associated with long-COVID in women.</ArticleTitle><Pagination><StartPage>1413</StartPage><EndPage>1418</EndPage><MedlinePgn>1413-1418</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5664/jcsm.9898</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVES">Sleep disturbance is common in long-COVID (LC). Restless legs syndrome (RLS) is characterized by sleep disturbance and has been reported after viral infections. Therefore, we evaluated RLS symptoms cross-sectionally in individuals with LC at both current and pre-coronavirus disease 2019 (pre-COVID-19) time points.</AbstractText><AbstractText Label="METHODS">Adults on LC-focused Facebook pages were recruited for an online assessment of symptoms before COVID-19 infection and during their present LC state in a cross-sectional manner. The LC group documented baseline symptoms retrospectively. Questions were included about the presence/severity of RLS symptoms and assessments of fatigue, quality of life, and sleep apnea. A control group was recruited and included individuals &#x2265; 18 years of age who never had overt symptoms of COVID-19. Pregnancy was an exclusion criterion for both groups.</AbstractText><AbstractText Label="RESULTS">There were 136 participants with LC (89.7% females, age 46.9 &#xb1; 12.9 years) and 136 controls (65.4% females, age 49.2 &#xb1; 15.5). RLS prevalence in females with LC was 5.7% pre-COVID-19 and 14.8% post-COVID-19 (<i>P</i> &lt; .01) vs 6.7% in control females. Severity of RLS was moderate in both groups. Logistic regression predicting post-COVID-19 RLS among females with LC failed to find significant effects of hospitalization, sleep apnea, neuropathic pain severity, or use of antihistamines and antidepressants.</AbstractText><AbstractText Label="CONCLUSIONS">The baseline prevalence of RLS in females with LC was similar to the general population group as well as to patients in epidemiological studies. The prevalence significantly increased in the LC state. Postinfectious immunological mechanisms may be at play in the production for RLS symptoms.</AbstractText><AbstractText Label="CITATION">Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Restless legs syndrome is associated with long-COVID in women. <i>J Clin Sleep Med</i>. 2022;18(5):1413-1418.</AbstractText><CopyrightInformation>&#xa9; 2022 American Academy of Sleep Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weinstock</LastName><ForeName>Leonard B</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Departments of Medicine, Missouri Baptist Medical Center and Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brook</LastName><ForeName>Jill B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Biostatistics, Private Practice, Truckee, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walters</LastName><ForeName>Arthur S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Division of Sleep Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goris</LastName><ForeName>Ashleigh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infection Prevention and Control and Clinical Quality, Missouri Baptist Medical Center, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afrin</LastName><ForeName>Lawrence B</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Department of Mast Cell Studies, Hematology/Oncology, AIM Center for Personalized Medicine, Purchase, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molderings</LastName><ForeName>Gerhard J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Institute of Human Genetics, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Sleep Med</MedlineTA><NlmUniqueID>101231977</NlmUniqueID><ISSNLinking>1550-9389</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="Y">Pregnancy Complications, Infectious</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012148" MajorTopicYN="Y">Restless Legs Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012891" MajorTopicYN="Y">Sleep Apnea Syndromes</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012893" MajorTopicYN="Y">Sleep Wake Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">long-haul-COVID</Keyword><Keyword MajorTopicYN="N">restless legs syndrome</Keyword></KeywordList><CoiStatement>All authors have seen and approved this manuscript. Work for this study was performed at Missouri Baptist Medical Center, St. Louis, MO. This study was partially funded by Missouri Baptist Healthcare Foundation. Dr. Weinstock and Dr. Afrin are uncompensated volunteer medical advisors to the startup company MC Sciences, Ltd. Dr. Walters has received research funding from the National Institutes of Health, Xenoport, Arbor, and Mundi Pharma. Dr. Molderings is the chief medical officer of the startup company MC Sciences, Ltd. The other authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>28</Day><Hour>23</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35484639</ArticleId><ArticleId IdType="pmc">PMC9059584</ArticleId><ArticleId IdType="doi">10.5664/jcsm.9898</ArticleId><ArticleId IdType="pii">jcsm.9898</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yong SJ . Long-haul COVID-19: putative pathophysiology, risk factors, and treatments . Infect Dis (Lond). 2021. ; 22 ( 5 ): 1 &#x2013; 18 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>
FAIR Health White Paper
. A detailed study of patients with long-haul COVID. 
https://mma.prnewswire.com/media/1533546/A_Detailed_Study_of_Patients_with_Long_Haul_COVID__An_Analysis_of_Private_Health.pdf?p=pdf
. June 15, 
2021. 
. Last accessed August 14, 2021.
</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, et al. Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: a multicenter study. J Infect. 2021;83(2):237--279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110627</ArticleId><ArticleId IdType="pubmed">33984399</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy. 2021;51(9):1107--1120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L , Jin H , Wang M , et al. . Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China . JAMA Neurol. 2020. ; 77 ( 6 ): 683 &#x2013; 690 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-S&#xe1;nchez CM , D&#xed;az-Maroto I , Fern&#xe1;ndez-D&#xed;az E , et al. . Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry . Neurology. 2020. ; 95 ( 8 ): e1060 &#x2013; e1070 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G , Palaiodimou L , Zand R , et al. . COVID-19 and cerebrovascular diseases: a comprehensive overview . Ther Adv Neurol Disord. 2020. ; 13 : 1756286420978004 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7727052</ArticleId><ArticleId IdType="pubmed">33343709</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M , Sali&#xe9; H , Tanevski J , et al. . Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions . Immunity. 2021. ; 54 ( 7 ): 1594 &#x2013; 1610.e11 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Munro KJ , Uus K , Almufarrij I , Chaudhuri N , Yioe V . Persistent self-reported changes in hearing and tinnitus in post-hospitalisation COVID-19 cases . Int J Audiol. 2020. ; 59 ( 12 ): 889 &#x2013; 890 .</Citation><ArticleIdList><ArticleId IdType="pubmed">32735466</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S , Whitelaw S . Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients . Immunol Res. 2021. ; 69 ( 2 ): 205 &#x2013; 211 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofield JR . Persistent antiphospholipid antibodies, mast cell activation syndrome, postural orthostatic tachycardia syndrome and post-COVID syndrome: 1 Year On . Eur J Case Rep Intern Med. 2021. ; 8 ( 3 ): 002378 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8046288</ArticleId><ArticleId IdType="pubmed">33869099</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB , Self S , Menk J , Lazarchick J . Characterization of mast cell activation syndrome . Am J Med Sci. 2017. ; 353 ( 3 ): 207 &#x2013; 215 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5341697</ArticleId><ArticleId IdType="pubmed">28262205</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB , Brook JB , Walters AS , Goris A , Afrin LB , Molderings GJ . Mast cell activation symptoms are prevalent in Long-COVID . Int J Infect Dis. 2021. ; 112 : 217 &#x2013; 226 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J , Zhou F , Hou W , et al. . The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis . Ann N Y Acad Sci. 2021. ; 1486 ( 1 ): 90 &#x2013; 111 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675607</ArticleId><ArticleId IdType="pubmed">33009668</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C , G&#xf3;mez-Mayordomo V , de-la-Llave-Rinc&#xf3;n AI , et al. . Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: A multicenter study . J Infect. 2021. ; 83 ( 4 ): 496 &#x2013; 522 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236125</ArticleId><ArticleId IdType="pubmed">34192525</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed GK , Khedr EM , Hamad DA , Meshref TS , Hashem MM , Aly MM . Long term impact of Covid-19 infection on sleep and mental health: A cross-sectional study . Psychiatry Res. 2021. ; 305 : 114243 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8507572</ArticleId><ArticleId IdType="pubmed">34673325</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C , Huang L , Wang Y , et al. . 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study . Lancet. 2021. ; 397 ( 10270 ): 220 &#x2013; 232 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Trenkwalder C , Allen R , H&#xf6;gl B , Paulus W , Winkelmann J . Restless legs syndrome associated with major diseases: A systematic review and new concept . Neurology. 2016. ; 86 ( 14 ): 1336 &#x2013; 1343 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4826337</ArticleId><ArticleId IdType="pubmed">26944272</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferini-Strambi L , Walters AS , Sica D . The relationship among restless legs syndrome (Willis-Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular disease . J Neurol. 2014. ; 261 ( 6 ): 1051 &#x2013; 1068 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057632</ArticleId><ArticleId IdType="pubmed">23963470</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB , Walters AS , Paueksakon P . Restless legs syndrome&#x2014;theoretical roles of inflammatory and immune mechanisms . Sleep Med Rev. 2012. ; 16 ( 4 ): 341 &#x2013; 354 .</Citation><ArticleIdList><ArticleId IdType="pubmed">22258033</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin JW , Lee JH , Kim H , et al. . Bioinformatic analysis of proteomic data for iron, inflammation, and hypoxic pathways in restless legs syndrome . Sleep Med. 2020. ; 75 ( 11 ): 448 &#x2013; 455 .</Citation><ArticleIdList><ArticleId IdType="pubmed">32992101</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters AS , Ondo WG , Zhu W , Le W . Does the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem study . J Neurol Sci. 2009. ; 279 ( 1-2 ): 62 &#x2013; 65 .</Citation><ArticleIdList><ArticleId IdType="pubmed">19167016</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdal Y , Akdogan O , Nalbantoglu M , Kavasoglu G , Emre U . Autonomic dysfunction in restless legs syndrome . Sleep Breath. 2020. ; 24 ( 3 ): 995 &#x2013; 999 .</Citation><ArticleIdList><ArticleId IdType="pubmed">31520300</ArticleId></ArticleIdList></Reference><Reference><Citation>Happe S , Kundm&#xfc;ller L , Reichelt D , Husstedt IW , Evers S . Comorbidity of restless legs syndrome and HIV infection . J Neurol. 2007. ; 254 ( 10 ): 1401 &#x2013; 1406 .</Citation><ArticleIdList><ArticleId IdType="pubmed">17934881</ArticleId></ArticleIdList></Reference><Reference><Citation>Tembl JI , Ferrer JM , Sevilla MT , Lago A , Mayordomo F , Vilchez JJ . Neurologic complications associated with hepatitis C virus infection . Neurology. 1999. ; 53 ( 4 ): 861 &#x2013; 864 .</Citation><ArticleIdList><ArticleId IdType="pubmed">10489056</ArticleId></ArticleIdList></Reference><Reference><Citation>Tony AA , Tony EA , Ali SB , Ezzeldin AM , Mahmoud AA . COVID-19-associated sleep disorders: A case report . Neurobiol Sleep Circadian Rhythms. 2020. ; 9 : 100057 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7486182</ArticleId><ArticleId IdType="pubmed">32954046</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco B , Morais MA , Holanda ASS , Manconi M , de Mello MT , Esteves AM . Impact of Covid-19 on the restless legs syndrome . Sleep Sci. 2020. ; 13 ( 3 ): 186 &#x2013; 190 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755267</ArticleId><ArticleId IdType="pubmed">33381285</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vries J , Michielsen HJ , Van Heck GL . Assessment of fatigue among working people: a comparison of six questionnaires . Occup Environ Med. 2003. ; 60 ( Suppl 1 ): i10 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1765720</ArticleId><ArticleId IdType="pubmed">12782741</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendriks C , Drent M , Elfferich M , De Vries J . The Fatigue Assessment Scale: Quality and availability in sarcoidosis and other diseases . Curr Opin Pulm Med. 2018. ; 24 ( 5 ): 495 &#x2013; 503 .</Citation><ArticleIdList><ArticleId IdType="pubmed">29889115</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestroni G , Bertolotti G . L&#x2019;EuroQol-5D (EQ-5D): Uno strumento per la misura della qualit&#xe0; della vita . [EuroQol-5D (EQ-5D): An instrument for measuring quality of life]. Monaldi Arch Chest Dis. 2012. ; 78 ( 3 ): 155 &#x2013; 159 .</Citation><ArticleIdList><ArticleId IdType="pubmed">23614330</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung F , Abdullah HR , Liao P . STOP-Bang Questionnaire: a practical approach to screen for obstructive sleep apnea . Chest. 2016. ; 149 ( 3 ): 631 &#x2013; 638 .</Citation><ArticleIdList><ArticleId IdType="pubmed">26378880</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen RP , Picchietti DL , Garcia-Borreguero D , et al. ; International Restless Legs Syndrome Study Group . Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria&#x2014;history, rationale, description, and significance . Sleep Med. 2014. ; 15 ( 8 ): 860 &#x2013; 873 .</Citation><ArticleIdList><ArticleId IdType="pubmed">25023924</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen RP , Burchell BJ , MacDonald B , Hening WA , Earley CJ . Validation of the self-completed Cambridge-Hopkins questionnaire (CH-RLSq) for ascertainment of restless legs syndrome (RLS) in a population survey . Sleep Med. 2009. ; 10 ( 10 ): 1097 &#x2013; 1100 .</Citation><ArticleIdList><ArticleId IdType="pubmed">19195928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharon D , Allen RP , Martinez-Martin P , et al. International RLS Study Group . Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale - The sIRLS . Sleep Med. 2019. ; 54 : 94 &#x2013; 100 .</Citation><ArticleIdList><ArticleId IdType="pubmed">30529783</ArticleId></ArticleIdList></Reference><Reference><Citation>Canafax DM , Bhanegaonkar A , Bharmal M , Calloway M . Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials . BMC Neurol. 2011. ; 11 ( 1 ): 48 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3120662</ArticleId><ArticleId IdType="pubmed">21527006</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE , Assaf GS , McCorkell L , et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact . EClinicalMedicine. 2021. ; 38 : 101019 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Younas A , Waheed S , Khawaja S , Imam M , Borhany M , Shamsi T . Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan . Transfus Apheresis Sci. 2020. ; 59 ( 6 ): 102923 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7444608</ArticleId><ArticleId IdType="pubmed">32868226</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanji JN , Zelyas N , MacDonald C , et al. . False negative rate of COVID-19 PCR testing: a discordant testing analysis . Virol J. 2021. ; 18 ( 1 ): 13 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7794619</ArticleId><ArticleId IdType="pubmed">33422083</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittom S , Dumont M , Petit D , et al. . Effects of melatonin and bright light administration on motor and sensory symptoms of RLS . Sleep Med. 2010. ; 11 ( 4 ): 351 &#x2013; 355 .</Citation><ArticleIdList><ArticleId IdType="pubmed">20226733</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>